Physician

Carrie H Hall, M.D.

According to 2025 Medicare claims, Carrie Hall, M.D. (NPI: 1467478974) practices dermatology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is MAY RIVER DERMATOLOGY (NPI: 1770723512; TIN: 264378964) and primary practice location at 29926-2841.

Hall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,542 traditional Medicare patients, billed 9,367 HCPCS/CPT codes, and received $419,622 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 694 prescription claims across 340 beneficiaries totaling $509,650 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 7 records totaling $209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $105,908 to $509,650. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$291K$582K2015 Medicare payment: $271,735 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $334,604 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $415,767 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $473,131 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $581,834 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $497,620 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $528,301 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $472,745 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $499,918 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $419,622 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1206,492$271,735
20161,4868,097$334,604
20171,87011,567$415,767
20181,95013,206$473,131
20191,99214,036$581,834
20201,81810,906$497,620
20211,72410,806$528,301
20221,71610,073$472,745
20231,70510,917$499,918
20241,5429,367$419,622

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$300K$599K2015 Drug cost: $105,908 (USD; Tot_Drug_Cst)2016 Drug cost: $87,277 (USD; Tot_Drug_Cst)2017 Drug cost: $190,451 (USD; Tot_Drug_Cst)2018 Drug cost: $260,365 (USD; Tot_Drug_Cst)2019 Drug cost: $322,260 (USD; Tot_Drug_Cst)2020 Drug cost: $399,480 (USD; Tot_Drug_Cst)2021 Drug cost: $392,152 (USD; Tot_Drug_Cst)2022 Drug cost: $319,333 (USD; Tot_Drug_Cst)2023 Drug cost: $599,293 (USD; Tot_Drug_Cst)2024 Drug cost: $509,650 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015240512$105,908
2016301625$87,277
2017427774$190,451
2018465903$260,365
2019503934$322,260
2020459887$399,480
2021424715$392,152
2022373711$319,333
2023398782$599,293
2024340694$509,650

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths379448$74
11102Biopsy of related skin growth, first growth362443$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1501,711$58
17000Destruction of precancer skin growth, 1 growth658892$36
17003Destruction of precancer skin growth, 2-14 growths5183,611$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab13392$91,019
OtezlaApremilast14420$78,959
FluorouracilFluorouracil561,560$2,971
Clobetasol PropionateClobetasol Propionate811,991$2,109
Hydroxychloroquine SulfateHydroxychloroquine Sulfate20860$1,264

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$209ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carrie H. Hall, M.D.?

Tedicare shows public-source Medicare data for Carrie H. Hall, M.D. (NPI 1467478974), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carrie H. Hall, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carrie H. Hall, M.D.?

Carrie H. Hall, M.D. is linked to MAY RIVER DERMATOLOGY (billing NPI 1770723512) in the available physician profile data.

Does Carrie H. Hall, M.D. have Open Payments data?

Carrie H. Hall, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.